Evidence map›Paper›PMID 29934326›Full record

ArticleMolecular cancer research : MCR2018

Autocrine Fibronectin Inhibits Breast Cancer Metastasis.

Aparna Shinde, Sarah Libring, Aktan Alpsoy, Ammara Abdullah, James A Schaber, Luis Solorio, Michael K Wendt

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Premetastatic niche mechanics and organotropism in breast cancer.npj biological physics and mechanics · 2025
    Review
  7. Review
  8. Article
  9. Shaping Oncogenic Microenvironments: Contribution of Fibronectin.Frontiers in cell and developmental biology · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. Multi-feature-Based Robust Cell Tracking.Annals of biomedical engineering · 2023
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. A Bayesian approach to estimate the diffusion coefficient of Rhodamine 6G in breast cancer spheroids.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Article
  19. Article
  20. Collagen- and hyaluronic acid-based hydrogels and their biomedical applications.Materials science & engineering. R, Reports : a review journal · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Aparna ShindeDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana.ORCID 0000-0002-0822-1313
Sarah LibringDepartment of Biomedical Engineering, Purdue University, West Lafayette, Indiana.
Aktan AlpsoyDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana.
Ammara AbdullahDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana.
James A SchaberBindley Bioscience Center, Purdue University, West Lafayette, Indiana.
Luis SolorioDepartment of Biomedical Engineering, Purdue University, West Lafayette, Indiana. mwendt@purdue.edu lsolorio@purdue.edu.
Michael K WendtDepartment of Biomedical Engineering, Purdue University, West Lafayette, Indiana. mwendt@purdue.edu lsolorio@purdue.edu.
Purdue University West Lafayette · US

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI Andrea L Kasinski · 1985 to 2026
$43.4M
Overcoming metastatic resistance to ErbB-targeted therapiesR01CA207751 · NCI · PURDUE UNIVERSITY · PI WENDT, MICHAEL KEITH · 2017 to 2021
$1.7M
Engineering the Cancer MicroenvironmentR00CA198929 · NCI · PURDUE UNIVERSITY · PI SOLORIO, LUIS · 2017 to 2019
$697k
NCI NIH HHS P30 CA023168NCI NIH HHS R00 CA198929NCI NIH HHS R01 CA207751
6 · The paper itself

Abstract

Both epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) are linked to metastasis via their ability to increase invasiveness and enhance tumor-initiating capacity. Growth factors, cytokines, and chemotherapies present in the tumor microenvironment (TME) are capable of inducing EMT, but the role of the extracellular matrix (ECM) in this process remains poorly understood. Here, a novel tessellated three-dimensional (3D) polymer scaffolding is used to produce a fibrillar fibronectin matrix that induces an EMT-like event that includes phosphorylation of STAT3 and requires expression of β1 integrin. Consistent with these findings, analysis of the METABRIC dataset strongly links high-level fibronectin (FN) expression to decreased patient survival. In contrast,

Indexed as

Autocrine CommunicationBreast NeoplasmsCell Line, TumorCell ProliferationEpithelial CellsEpithelial-Mesenchymal TransitionExtracellular MatrixFemaleFibronectinsGene Expression Regulation, NeoplasticHumansIntegrin beta1Neoplasm MetastasisNeoplastic Stem CellsSTAT3 Transcription FactorTumor MicroenvironmentFibronectinsIntegrin beta1STAT3 Transcription Factor

Identifiers

PMID29934326
PMCPMC6511995
OpenAlexW2809029138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.